chr2-1910225-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001303052.2(MYT1L):c.1817+15T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00674 in 1,609,404 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 45 hom. )
Consequence
MYT1L
NM_001303052.2 intron
NM_001303052.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.438
Publications
1 publications found
Genes affected
MYT1L (HGNC:7623): (myelin transcription factor 1 like) This gene encodes a member of the zinc finger superfamily of transcription factors whose expression, thus far, has been found only in neuronal tissues. The encoded protein belongs to a novel class of cystein-cystein-histidine-cystein zinc finger proteins that function in the developing mammalian central nervous system. Forced expression of this gene in combination with the basic helix-loop-helix transcription factor NeuroD1 and the transcription factors POU class 3 homeobox 2 and achaete-scute family basic helix-loop-helix transcription factor 1 can convert fetal and postnatal human fibroblasts into induced neuronal cells, which are able to generate action potentials. Mutations in this gene have been associated with an autosomal dominant form of cognitive disability and with autism spectrum disorder. Alternative splicing results in multiple variants. [provided by RefSeq, Jul 2017]
MYT1L Gene-Disease associations (from GenCC):
- intellectual disability, autosomal dominant 39Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-1910225-A-C is Benign according to our data. Variant chr2-1910225-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445848.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00495 (752/152066) while in subpopulation NFE AF = 0.00716 (487/67992). AF 95% confidence interval is 0.00664. There are 1 homozygotes in GnomAd4. There are 371 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 752 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00495 AC: 752AN: 151948Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
752
AN:
151948
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00612 AC: 1504AN: 245942 AF XY: 0.00658 show subpopulations
GnomAD2 exomes
AF:
AC:
1504
AN:
245942
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00693 AC: 10101AN: 1457338Hom.: 45 Cov.: 30 AF XY: 0.00707 AC XY: 5129AN XY: 725224 show subpopulations
GnomAD4 exome
AF:
AC:
10101
AN:
1457338
Hom.:
Cov.:
30
AF XY:
AC XY:
5129
AN XY:
725224
show subpopulations
African (AFR)
AF:
AC:
31
AN:
33422
American (AMR)
AF:
AC:
101
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
AC:
38
AN:
26106
East Asian (EAS)
AF:
AC:
0
AN:
39674
South Asian (SAS)
AF:
AC:
651
AN:
86152
European-Finnish (FIN)
AF:
AC:
382
AN:
51632
Middle Eastern (MID)
AF:
AC:
26
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
8501
AN:
1109642
Other (OTH)
AF:
AC:
371
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
521
1043
1564
2086
2607
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00495 AC: 752AN: 152066Hom.: 1 Cov.: 32 AF XY: 0.00499 AC XY: 371AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
752
AN:
152066
Hom.:
Cov.:
32
AF XY:
AC XY:
371
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
50
AN:
41468
American (AMR)
AF:
AC:
87
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5138
South Asian (SAS)
AF:
AC:
34
AN:
4812
European-Finnish (FIN)
AF:
AC:
80
AN:
10586
Middle Eastern (MID)
AF:
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
AC:
487
AN:
67992
Other (OTH)
AF:
AC:
7
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 22, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 26, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.